Correction
Accepted on 31 Mar 2025
Corrigendum: Targeting the PI3K/AKT/mTOR Pathway in Lung Cancer: Mechanisms and Therapeutic Targeting
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591443
Type at least 3 characters
602 articles
Original Research
Accepted on 25 Mar 2025
Sparstolonin B Nano-formulation Attenuates LPS-induced lung injury
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532391
Case Report
Accepted on 24 Mar 2025
Case Report: A Case of Felty's Syndrome with Initial Presentation of Pleural Effusion and Subsequent Escherichia coli Pyothorax
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529621
Original Research
Published on 14 Mar 2025
The impact of phthalates on asthma and chronic obstructive pulmonary disease: a comprehensive analysis based on network toxicology and molecular docking
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566965
- 456 views
Original Research
Accepted on 06 Mar 2025
Spiraea prunifolia var. simpliciflora leaves Ameliorate Inflammatory Responses and Oxidative Stress in PPE/LPSinduced Chronic Obstructive Pulmonary Disease Mouse Model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1501731
Original Research
Published on 05 Mar 2025
Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-ÎşB signaling inhibition: network pharmacology analysis and experimental evidence
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522690
- 691 views
Original Research
Published on 04 Mar 2025
Assessing medication adherence in adults with asthma and its effect on rescue therapy for exacerbations
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516062
- 433 views
Case Report
Published on 27 Feb 2025
Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1443609
- 745 views
Review
Published on 18 Feb 2025
Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516583
- 1,137 views
Editorial
Published on 14 Feb 2025
Editorial: Lung microbiome in health and disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565849
- 393 views
Case Report
Published on 05 Feb 2025
A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1508558
- 666 views
Review
Published on 29 Jan 2025
Silicosis: from pathogenesis to therapeutics
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516200
- 1,185 views
Mini Review
Published on 20 Jan 2025
The potential role of nanobodies in asthma therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1510806
- 1,159 views
Editorial
Published on 14 Jan 2025
Editorial: Methods in respiratory pharmacology 2023
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527053
- 429 views
Original Research
Published on 13 Jan 2025
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-ÎşB signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1502165
- 920 views
Editorial
Published on 13 Jan 2025
Editorial: Model organisms in respiratory pharmacology 2023
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1540222
- 524 views